INTRODUCTION
It is generally believed that carnitine palmitoyltransferase-I (CPT-I) is the most important enzyme for controlling the availability of long-chain acyl-CoAs for hepatic mitochondrial fl-oxidation [1] [2] [3] . Hepatic mitochondria contain two CPT activities. CPT-I is located in the mitochondrial outer membrane and is inhibited by malonyl-CoA [4] . Carnitine palmitoyltransferase-II (CPT-II) is located on the inside of the mitochondrial inner membrane and cannot be inhibited by malonylCoA [5] . CPT-I and CPT-II have been shown to be distinct proteins that are encoded by different genes [6, 7] . A complicating factor in the study of hepatic mitochondrial CPT-I is the fact that hepatic peroxisomal [8] and microsomal [9, 10] CPT activities exist that are sensitive to inhibition by malonyl-CoA. So far only the peroxisomal CPT has been shown to exhibit changes in sensitivity to malonyl-CoA inhibition [11] , but a recent report suggests that microsomal vesicles are involved in part of the sensitivity change of CPT-I [12] .
Hepatic mitochondrial CPT-I regulation occurs through modest changes in enzyme activity and alterations in the sensitivity of the enzyme to its physiological inhibitor, malonyl-CoA, as well as changes in hepatic malonyl-CoA concentrations. We have previously shown that in states of increased fatty acid oxidation such as fasting and diabetes, CPT-I activity measured under optimum assay conditions increases by approximately 50% while sensitivity to inhibition by malonyl-CoA decreases by a factor of 10, as measured by the K1 for malonyl-CoA [13] [14] [15] . The IC50 value for malonyl-CoA inhibition of CPT-I has generally been accepted as an indication of malonyl-CoA sensitivity even though the K, value (the equilibrium constant for dissociation of vation. CPT-I mRNA abundance was 7.5 times greater in livers of 48-h-starved rats and 14.6 times greater in livers of insulindependent diabetic rats compared with livers of fed rats. In H4IIE cells, insulin increased CPT-I sensitivity to inhibition by malonyl-CoA in 4 h, and sensitivity continued to increase up to 24 h after insulin addition. CPT-I mRNA levels in H4IIE cells were decreased by insulin after 4 h and continued to decrease so that at 24 h there was a 10-fold difference. The half-life of CPT-I mRNA was 4 h in the presence of actinomycin D or with actinomycin D plus insulin. These results suggest that insulin regulates CPT-I by inhibiting transcription of the CPT-I gene.
the enzyme-inhibitor complex) for CPT-I is the actual factor that changes in starvation and diabetes [13] [14] [15] . The K, value for CPT-I is a more precise estimate of sensitivity when comparing different conditions because the IC50 value is a theoretical function of not only the K1 value for the inhibitor but also the concentration and the Km of the competitive substrate [16] . Insulin is able to reverse the effects of diabetes on CPT-I activity and its malonyl-CoA sensitivity [14, 15] . It has been proposed that hepatic CPT activity is regulated by glucagon through protein phosphorylation [17, 18] , but there is no direct support for such a mechanism. Two reports have appeared suggesting that okadaic acid and agents that cause increased levels of cyclic AMP (cAMP) increase CPT-I activity in isolated hepatocytes and decrease its malonyl-CoA sensitivity [19, 20] ; however, recent studies have determined that phosphorylation is not directly involved in activation of CPT-I but that cAMP decreases malonyl-CoA levels by inhibiting acetyl-CoA carboxylase [21] .
Fatty acid oxidation and resultant ketogenesis are regulated in isolated rat hepatocytes in primary culture by dibutyryl-cAMP and insulin [22] . cAMP stimulates fatty acid oxidation in 24-h cultured hepatocytes [21] , while both insulin and proinsulin inhibit fatty acid oxidation in this system [22, 23] . Insulin reportedly inhibits ketogenesis by increasing the apparent Km of CPT-I for palmitoyl-CoA without affecting the Vmax of the enzyme [23] .
Hepatoma cells in culture have also been used for the study of mechanisms involved in the regulation of hepatic fatty acid oxidation. Rates of fatty acid oxidation in rat Fao cells and H4IIE cells [24] and in human HepG2 cells [25] [24, 25] . The lower rates of fatty acid oxidation, at least in Fao cells, are due to higher than normal malonyl-CoA concentrations and to a CPT-I that has an inherently greater sensitivity to inhibition by malonyl-CoA [24] .
Currently very little is known of transcriptional control for the CPT-I gene. Rat hepatic CPT-I mRNA has been reported to increase at birth, to remain elevated during the suckling period and to decrease after weaning on a high-carbohydrate diet [26] . CPT-I mRNA was also elevated in adult rat liver after 48 h of starvation [26] . Hormonal mechanisms responsible for these changes in mRNA are not known. It was speculated that high plasma glucagon or low plasma insulin might be responsible, but no direct effect of the pancreatic hormones was demonstrated [26] . We have recently reported that CPT-I mRNA abundance varied over a 40-fold range in response to thyroid hormone, which suggests regulation at the level of transcription [27] . In this paper, we have examined the regulation of CPT-I during starvation and diabetes and studied the regulatory properties of the peroxisomal and microsomal CPT activities during starvation. In addition, we have directly examined the effects of insulin on CPT-I activity, malonyl-CoA sensitivity and mRNA abundance in H4IIE cells. [13, 14] . All diabetic animals used for these studies had urine glucose > 200 mg/ml and urine ketone bodies > 8 mg/ml, while fed control and starved animals had no trace of glucose or ketone bodies in their urine. Starved and diabetic animals were examined when livers were removed to ensure that stomachs of starved animals were empty and that diabetic animals were very well-fed.
MATERIALS AND METHODS
Isolation of subcellular membranes and assay of CPT-1 Hepatic mitochondria were isolated by the method of Johnson and Lardy [28] with modifications as previously described [14] . The post-mitochondrial supernatant suspension was centrifuged at 20000 g for 20 min to remove light mitochondria and peroxisomes, and the resulting supernatant suspension was centrifuged at 100000 g for 60 min to collect microsomes. Mitochondria were purified further by centrifugation (50000 g for 60 min) in a swinging-bucket rotor through a self-generating density gradient formed by layering the mitochondrial suspensions over a 50 % Percoll solution. The mitochondrial fraction, which was collected from the gradient, was found to band between 12 and 18 mm from the bottom of the tube (top of tube = 50 mm), corresponding to densities of between 1.098 and 1.110 g/ml. Microsomes and peroxisomes band near the top of this gradient (25-45 mm from the bottom). Catalase [29] , UDP-glucuronosyltransferase [30] and monoamine oxidase [31] were measured as peroxisomal, microsomal and mitochondrial outer membrane markers respectively to determine the extent of purification. The Percoll gradient reduced peroxisomal contamination in the mitochondrial fraction by 90 % and reduced microsomal conenzymes. Monoamine oxidase-specific activity was increased 50% by Percoll treatment. Mitochondrial outer membranes were then isolated by hypotonic swelling of mitochondria followed by sucrose density gradient separation [32] . A modified procedure of Bremer [33] described earlier [34] was employed to measure CPT activity. Final concentrations in a total volume of 1 ml at 37°C were: 80 mM sucrose, 70 mM KCl, 70 mM imidazole (pH 7.0), 1 
Culture of H411E cells
Rat H4IIE hepatoma cells were grown on 100 cm plates in Dulbecco's modified Eagle's medium (DMEM)/nutrient mixture F-12 (DMEM/F-12) containing 50% fetal calf serum and 5 % calf serum. Cells were grown to 60-70 % confluence, then the medium was replaced with DMEM/F-12 plus dexamethasone (100 nM) overnight (16 h). Subsequently the medium was changed to either DMEM/F-12 plus dexamethasone (control cells) or DMEM/F-12 containing 100 nM insulin, 10 nM glucagon, 500 ,tM 8-chlorophenylthio-cAMP and 100 nM dexamethasone or combinations of these hormones. After additional time periods, as indicated in the Figures, cells were harvested by scraping from plates with a rubber spatula and used for measurement of CPT activity or for determination of mRNA abundance. For measurement of CPT activity, cells were homogenized in mitochondrial isolation medium [14] with three passes of a Teflon-glass homogenizer before centrifugation at 10000 g for 10 min at 4 'C. Approximately 95 + 6 % of monoamine oxidase activity was found in this pellet, which was used for assay of CPT-I after resuspension in mitochondrial isolation medium using four passes of a Teflon-glass homogenizer. Different plates, from which cells were removed by scraping and homogenized in guanidinium thiocyanate/phenol/chloroform, were used for determinations of mRNA abundance (below). Initial cell-culture experiments were conducted without an overnight period in the absence of serum and showed little or no effects of insulin on CPT-I mRNA levels when insulin was added for 18 h compared with 18-h controls containing only plain medium (results not shown).
Synthesis of cONA and cRNA probes Total RNA was isolated from fresh rat liver using the guanidinium thiocyanate/phenol/chloroform extraction procedure (RNAzol B from TEL-TEST Inc., Friendswood, TX, U.S.A.). The CPT-I cDNA was obtained by PCR amplification of rat liver mRNA. First-strand cDNA was synthesized from the rat liver RNA using random primers and avian-myelobastosis- Isolation of RNA and measurement of CPT-I mRNA After isolation of total RNA from fresh rat liver by the guanidinium thiocyanate/phenol/chloroform extraction procedure, CPT-I mRNA abundance was measured by ribonuclease protection or Northern blot analysis. The ribonuclease protection assay (RPA II Kit; Ambion) was performed by diluting 21 ,ug of rat liver RNA to 1 ,ug/,ul. A 1 ,ul aliquot was removed and hybridized with a 5 M excess of the human 18 S RNA antisense probe, assuming 18 S RNA constituted 20 % of the total RNA. The remaining 20 ,ug of RNA was hybridized with a 5 M excess of CPT-I cRNA, assuming that CPT-I mRNA constituted 0.1 % of the total mRNA. After the overnight hybridization at 45°C, single-stranded RNA was digested with a mixture of RNase A and RNase TI and protected fragments were analysed by denaturing 5 % PAGE followed by autoradiography. Autoradiographs were analysed using a scanning densitometer (model DNA 45; PDI, Huntington Station, NY, U.S.A.).
Northern analyses were conducted as described elsewhere [37] . Briefly, the RNA was resolved on an agarose gel and transferred to a Gene Screen Plus membrane (Dupont-NEN, Boston, MA, U.S.A.). The CPT-I DNA fragment was labelled using the Prime-it II random primer labelling kit (Stratagene, La Jolla, CA, U.S.A.) and [a-32P]dCTP. Hybridization of the probe to the membrane-bound mRNA was conducted overnight at 42 'C. The membranes were washed to remove non-specifically bound probe and exposed to XAR-5 film (Kodak, Rochester, NY, U.S.A.). Autoradiographs were analysed as described above. Table 1 The effects of starvation and diabetes on the activIty of CPT-I and mRNA abundance
Materials
The activity of CPT-I was measured in isolated mitochondrial outer membranes of livers of rats that were fed, starved for 48 h or made diabetic by injection of streptozotocin. Enzyme activity measurements were used to construct Lineweaver-Burk plots from which V values were derived. K values are taken from Dixon plots like those in Figure 1 . CPT-l mRNA and 18 S ribosomal RNA were measured by solution hybridization using total RNA isolated from rat liver as described in the Materials and methods section. RNA abundance was determined from densitometric measurements of autoradiographs of protected fragments of RNA derived from ribonuclease protection assays (illustrated in Figure 2 ). Relative abundance of CPT-1 mRNA was calculated with respect to the 18 S rRNA. All values are means+S.E.M. for four animals. *Values significantly different from the respective fed control value as determined by the Mann-Whitney U-test (P < 0.02).
Fed
Starved Diabetic 1.0 7.5 + 2.9* 14.6 + 2.6* chondrial outer membrane preparations, but we report here that Vmax values are even more elevated in the diabetic rat, strongly suggesting an effect of insulin. A high dose of streptozotocin was used in these studies to obtain diabetic animals that were insulindependent. We have previously shown that while CPT-I responds to decreased levels of insulin produced by a lower dose of streptozotocin at both 2 and 7 days, the enzyme is more responsive to the higher dose [15] . Furthermore, ketone bodies are not found in the urine unless the high dose is used [15] . The animals were monitored carefully to be certain that they were well fed and that kidney failure was avoided. All the diabetic animals in our studies possessed distended stomachs which contained more food than those of control animals. Urine samples (urination was not forced) were taken a few minutes before killing the animals. The urine contained high levels of glucose and ketone bodies but no protein.
The sensitivity of CPT-I to inhibition by malonyl-CoA was diminished in mitochondrial outer membranes by starvation and diabetes (Figure 1 ), as previously reported in experiments using whole mitochondria [13] [14] [15] . Positive co-operative inhibition was demonstrated in outer membrane preparations from fed and starved animals by the upward curvature of the Dixon plots, but this was not seen in outer membranes from diabetic animals ( Figure 1 ). This effect was seen previously only in fed animals when whole mitochondria were used [13] . K, values were all somewhat lower in the present study using isolated outer membranes, suggesting that purification of mitochondria may have removed contaminating peroxisomal or microsomal CPT activities (Table 1) ; however, differences among the fed, starved and diabetic groups were similar to previous results with the K1 value increasing 8-fold in starved animals and 50-fold in diabetic animals. The theoretical extent of inhibition by malonyl-CoA was also examined to be certain that CPT-II activity of the mitochondrial inner membrane had been eliminated as a possible contaminant of the outer membrane preparations. Maximum inhibition values by malonyl-CoA (Imax) [39] were 102 + 50%, indicating that all CPT in the outer membrane preparations was sensitive to malonyl-CoA inhibition and therefore no detectable contamination by CPT-II or any other non-inhibitable CPT was present.
In these studies with mitochondrial outer membranes, contamination from peroxisomal and microsomal enzymes was Rats fed a chow diet ad libitum were used as controls for one group of rats that were starved for 48 h and another group of rats that were made diabetic by the injection of streptozotocin as indicated in the Materials and methods section. Activity measurements were carried out using outer membranes of mitochondria purified on Percoll gradients after separation from microsomes. Table 1 as means+S.E.M. (Table 2 ). This induction was greater than the effect on the mitochondrial enzyme. The sensitivity of these enzymes to inhibition by malonyl-CoA was diminished 3-4-fold by starvation. We have previously observed an effect of starvation on the peroxisomal enzyme [11] , but this is the first report of such an effect on the microsomal enzyme.
Changes in CPT-L activity might be explained by either increased synthesis of the CPT-I protein, a post-translational modification of CPT-I or a change in the phospholipid composition of the mitochondrial outer membrane. Evidence has been presented to indicate that there is no direct involvement of phosphorylation in the regulation of CPT-I activity [21] . We have shown that the addition of cardiolipin and some other phospholipids to mitochondria and mitochondrial outer membranes increases sensitivity to inhibition by malonyl-CoA and also increases CPT-I activity [40] . However, starvation and diabetes produce increased enzyme activity while having the opposite effect on sensitivity to inhibition by malonyl-CoA [13] [14] [15] . These observations suggest that changes in membrane phospholipid composition may not act by the same mechanism as starvation and diabetes to increase CPT-I activity.
Insulin regulates the synthesis of a number of liver proteins by altering the transcription of their genes (see [41, 42] for reviews). Although many studies have shown increased rates of transcription with insulin treatment, there are also examples of insulin inhibiting transcription [43, 44] . Initially we examined the effects of starvation and diabetes on the relative abundance of CPT-I mRNA in rat liver. A cDNA for CPT-I was generated by PCR amplification of rat liver RNA following reverse transcription. The region of CPT-I selected for PCR amplification was the 122-amino-acid N-terminus of CPT-I that had no sequence similarity to CPT-II and other proteins, as determined by screening through GenBank. The CPT-I cDNA probe was tested against RNA prepared from rat liver in a Northern blot analysis and was found to hybridize to a band of 4.7 kb [27] . This mRNA was identical with the size reported by Esser et al. for CPT-I [7] .
To quantify the changes in CPT-I mRNA abundance in livers of fed, starved and diabetic rats, we used the ribonuclease protection assay. The full-length CPT-I RNA probe (generated from the T7 promoter) is 425 bp long. After hybridization and ribonuclease digestion, the protected fragment was found to be between 360 and 370 bp, corresponding to the predicted size of the protected fragment of 366 bp. Figure 2 shows the results of a protection assay using liver RNA isolated from fed, starved and diabetic rats. Densitometric quantification of the bands from autoradiographs indicated a greater than 7-fold increase in CPT-I mRNA levels in starved rats and a 14-fold increase in diabetic rats (Table 1 ). These data demonstrate a clear correlation between CPT-I mRNA concentrations and measured CPT-I activity and suggest that CPT-I is regulated at the transcriptional level during starvation and diabetes. Although starvation and diabetes produce very large changes in CPT-I mRNA abundance, these data cannot rule out the possibility that other factors, such as changes in mRNA stability, may contribute to the overall effect.
Rat H4IIE hepatoma cells were used to examine the effects of insulin and its counter-regulatory hormone glucagon on CPT-I Table 1 . activity and malonyl-CoA sensitivity. To determine a time course for insulin effects on CPT-I in these cells, we measured malonyl-CoA inhibition of CPT activity over a period of 24 h. We found that the sensitizing effects of insulin on CPT activity could be seen at 4 h after insulin addition and that sensitivity to inhibition by malonyl-CoA continued to increase up to 24 h ( Figure 3 ). The IC50 for malonyl-CoA inhibition was decreased from 2 to 0.6 #M, not only demonstrating an effect of insulin on these hepatoma cells, but also showing the greater sensitivity to malonyl-CoA in these cells than in normal liver, as previously indicated [24] . It has been reported that glucagon and cAMP increase oleate oxidation and decrease malonyl-CoA sensitivity of CPT-I in cultured fetal rabbit hepatocytes following a lag period of 12 h, but there was no change in activity of CPT-I with these agents [45] . Insulin decreased oleate oxidation and increased malonyl-CoA sensitivity in rabbit hepatocytes at 24 and 48 h, but no change in the activity of CPT-I was found. Our results may have differed because the rabbit hepatocytes were derived from fetal animals of a different species examined in primary cultures, whereas our studies were conducted using a hepatoma cell line. Another previous report has indicated that cultured Fao hepatoma cells oxidized oleate at a slow rate that was not affected by cAMP or insulin and that insulin increased malonylCoA sensitivity without affecting CPT-I activity [24] . Two differences between the latter study and ours were the lack of dexamethasone in the Fao cell cultures and the fact that a relatively short incubation time with insulin (4 h) was used for the Fao cells.
Insulin treatment of H4IIE cells produced a decrease in CPT-I mRNA abundance that approximated the same time course as that seen for malonyl-CoA sensitivity (Figure 4) . CPT CPT-I is the primary regulatory enzyme allowing long-chain fatty acids to be oxidized in mitochondria. Its importance as a regulatory enzyme in starvation and diabetes is demonstrated by the multiple levels of regulation that have been observed to influence its activity, including substrate-level inhibition, allosteric inhibition by malonyl-CoA, modulation of its sensitivity to inhibition by malonyl-CoA and changes in its intrinsic activity. Data presented here represent the first demonstration that insulin plays a major role in regulating CPT-I mRNA abundance in liver, and that insulin exerts its effect on CPT-I primarily by decreasing gene transcription.
